We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Zoetis
ZTS
$32.4B
| $86.8M | 0.21% |
656,214
+50,575
| +8% | +$6.28M |
|
127
Morgan Stanley
MS
$331B
| $85.2M | 0.21% |
1,666,006
+181,900
| +12% | +$8.61M |
|
128
TJX Companies
TJX
$174B
| $84.8M | 0.21% |
+1,388,422
| New | +$82.1M |
|
|
WPX
129
DELISTED
WPX Energy, Inc.
WPX
| $83.8M | 0.21% |
6,096,000
-2,220,000
| -27% | -$23.7M |
|
130
American Express
AXP
$227B
| $83.6M | 0.21% |
671,225
+171,200
| +34% | +$20.5M |
|
|
SUM
131
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $82.8M | 0.2% |
3,521,448
-128,040
| -4% | -$2.91M |
|
132
Gilead Sciences
GILD
$162B
| $82.1M | 0.2% |
1,263,425
-78,000
| -6% | -$5.08M |
|
133
EOG Resources
EOG
$79.2B
| $81.9M | 0.2% |
977,400
-35,200
| -3% | -$2.58M |
|
134
Marvell Technology
MRVL
$168B
| $81.8M | 0.2% |
3,081,261
-194,822
| -6% | -$4.94M |
|
135
Willis Towers Watson
WTW
$31.7B
| $81.5M | 0.2% |
403,675
+32,900
| +9% | +$6.31M |
|
|
BECN
136
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $80.9M | 0.2% |
2,529,578
-290,544
| -10% | -$9.19M |
|
137
Intuit
INTU
$86.5B
| $79.5M | 0.2% |
303,600
-14,900
| -5% | -$3.9M |
|
138
General Dynamics
GD
$104B
| $78.6M | 0.19% |
445,427
-173,408
| -28% | -$31.1M |
|
139
Vistra
VST
$50B
| $78.2M | 0.19% |
3,399,920
-3,250,000
| -49% | -$83.9M |
|
140
Chubb
CB
$135B
| $77.9M | 0.19% |
500,224
-5,100
| -1% | -$780K |
|
141
CME Group
CME
$96.3B
| $77M | 0.19% |
383,431
-33,400
| -8% | -$6.85M |
|
142
Target
TGT
$65.6B
| $75.6M | 0.19% |
589,529
-30,940
| -5% | -$3.63M |
|
143
Baxter International
BAX
$13.5B
| $74.9M | 0.18% |
895,316
+99,919
| +13% | +$8.27M |
|
144
Blackrock
BLK
$169B
| $74.6M | 0.18% |
148,380
-300
| -0.2% | -$142K |
|
145
United Parcel Service
UPS
$88.6B
| $74.1M | 0.18% |
632,589
-132,800
| -17% | -$15.7M |
|
146
Karyopharm Therapeutics
KPTI
$43.5M
| $72.6M | 0.18% |
252,467
+139,134
| +123% | +$30.2M |
|
147
Truist Financial
TFC
$63.3B
| $72M | 0.18% |
1,278,074
+956,874
| +298% | +$51.8M |
|
148
Becton Dickinson
BDX
$45.6B
| $71.6M | 0.18% |
269,873
-15,224
| -5% | -$3.8M |
|
149
Toyota
TM
$224B
| $70.9M | 0.17% |
504,208
| – | – |
|
150
SLB Ltd
SLB
$73.6B
| $70.9M | 0.17% |
1,762,467
+33,400
| +2% | +$1.19M |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.